Epilepsy Advocate
Strength in numbers™
Quick Poll

Are you new to the community?

Sign up for the Epilepsy Advocate community and receive:
  • quarterly issues of Epilepsy Advocate magazine
  • monthly e-mails customized for those living with epilepsy
    or caregivers

Join a group that shares information, insight, and support.

We are committed to protecting your privacy. Please see the UCB, Inc. Privacy Policy.

Questions marked with an asterisk (*) are required.

* Please answer the following questions about your or your friend/loved one’s epilepsy….

1. Overall, how much of an impact does your or your friend/loved one’s epilepsy and/or seizures have on your/his/her personal life (ie, personal relationships, leisure, home life)?

1 2 3 4 5 6 7 8 9 10 11
   No
   Impact
Moderate
Impact
Major   
Impact   

2. I constantly worry that I or my friend/loved one will hurt myself/herself/himself or others while having a seizure.

1 2 3 4 5 6 7 8 9 10 11
   Totally
   Disagree
Neither Agree
nor Disagree
Totally   
Agree   

3. I actively seek out information about new ways to cope with my or my friend/loved one’s epilepsy.

1 2 3 4 5 6 7 8 9 10 11
   Totally
   Disagree
Neither Agree
nor Disagree
Totally   
Agree   

4. How concerned are you, if at all, about the possibility of you or your friend/loved one having a seizure in the next 12 months?

1 2 3 4 5 6 7 8 9 10 11
   Not at all Somewhat Extremely   

5. How likely, if at all, do you think it is that you or your friend/loved one will be restricted from driving in the future due to epilepsy/seizures?

1 2 3 4 5 6 7 8 9 10 11
   Not at all Somewhat Extremely   

* Are you or a friend/loved one taking any of the following medications? (Check all that apply.)

Prescription Medication















Yes, I would like to receive the FREE Epilepsy Advocate magazine and other communications from the Epilepsy Advocate community. By checking this box, I give UCB, Inc. permission to send me the Epilepsy Advocate magazine and other communications from the Epilepsy Advocate community.

Yes, I would like to receive information about a leading antiepilepsy medication and other product updates from UCB, Inc. By checking this box, I give UCB, Inc. permission to send me information about a leading antiepilepsy medication and other product updates.

* How would you prefer to receive emails?

Depakote and Depakote ER are registered trademarks of Abbott Laboratories.
Dilantin is a registered trademark of Pfizer Inc.
Keppra is a registered trademark of UCB S.A.
Lamictal is a registered trademark of GlaxoSmithKline.
Lyrica is a registered trademark of Pfizer Inc.
Neurontin is a registered trademark of Pfizer Inc.
Tegretol and Tegretol XR are registered trademarks of Novartis Pharmaceuticals Corporation.
Topamax is a registered trademark of Ortho-McNeil Neurologics, Inc.
Trileptal is a registered trademark of Novartis Pharmaceuticals Corporation.
Zonegran is a registered trademark of Dainippon Pharmaceutical Co. Ltd. and licensed exclusively to Eisai Inc.